Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Insights and Forecast to 2028

Table Of Contents

1 Study Coverage

1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Introduction 1.2 Market by Type 1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Salicylates 1.2.3 Propionic acid derivatives 1.2.4 Acetic acid derivatives 1.2.5 Enolic acid (Oxicam) derivatives 1.2.6 Anthranilic acid derivatives (Fenamates) 1.2.7 Selective COX-2 inhibitors (Coxibs) 1.2.8 Sulfonanilides 1.3 Market by Application 1.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Human 1.3.3 Animals 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered2 Executive Summary 2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Estimates and Forecasts 2017-2028 2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Estimates and Forecasts 2017-2028 2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region 2.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022) 2.4.2 Global Sales Non-steroidal Anti-inflammatory Drugs (NSAID) by Region (2023-2028) 2.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region 2.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022) 2.5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa3 Competition by Manufacturers 3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers 3.1.1 Global Top Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers by Sales (2017-2022) 3.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) in 2021 3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers 3.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (2017-2022) 3.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2021 3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans4 Market Size by Type 4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type 4.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historical Sales by Type (2017-2022) 4.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Sales by Type (2023-2028) 4.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028) 4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type 4.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historical Revenue by Type (2017-2022) 4.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Revenue by Type (2023-2028) 4.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028) 4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type 4.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2017-2022) 4.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Type (2023-2028)5 Market Size by Application 5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application 5.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historical Sales by Application (2017-2022) 5.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Sales by Application (2023-2028) 5.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028) 5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application 5.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historical Revenue by Application (2017-2022) 5.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Revenue by Application (2023-2028) 5.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028) 5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application 5.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2017-2022) 5.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Application (2023-2028)6 North America 6.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type 6.1.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028) 6.1.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028) 6.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application 6.2.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028) 6.2.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028) 6.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country 6.3.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2028) 6.3.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada7 Europe 7.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type 7.1.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028) 7.1.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028) 7.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application 7.2.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028) 7.2.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028) 7.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country 7.3.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2028) 7.3.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia8 Asia Pacific 8.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type 8.1.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028) 8.1.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028) 8.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application 8.2.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028) 8.2.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028) 8.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region 8.3.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2028) 8.3.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines9 Latin America 9.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type 9.1.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028) 9.1.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028) 9.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application 9.2.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028) 9.2.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028) 9.3 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country 9.3.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2028) 9.3.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina10 Middle East and Africa 10.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type 10.1.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028) 10.1.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028) 10.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application 10.2.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028) 10.2.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028) 10.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country 10.3.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2028) 10.3.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia11 Company Profiles 11.1 Bayer 11.1.1 Bayer Corporation Information 11.1.2 Bayer Overview 11.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Bayer Recent Developments 11.2 Ecotrin 11.2.1 Ecotrin Corporation Information 11.2.2 Ecotrin Overview 11.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Ecotrin Recent Developments 11.3 Generic 11.3.1 Generic Corporation Information 11.3.2 Generic Overview 11.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Generic Recent Developments 11.4 St. Joseph 11.4.1 St. Joseph Corporation Information 11.4.2 St. Joseph Overview 11.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 St. Joseph Recent Developments 11.5 Elanco 11.5.1 Elanco Corporation Information 11.5.2 Elanco Overview 11.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Elanco Recent Developments 11.6 Zoetis 11.6.1 Zoetis Corporation Information 11.6.2 Zoetis Overview 11.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Zoetis Recent Developments 11.7 Boehringer Ingelheim 11.7.1 Boehringer Ingelheim Corporation Information 11.7.2 Boehringer Ingelheim Overview 11.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Boehringer Ingelheim Recent Developments 11.8 Merial 11.8.1 Merial Corporation Information 11.8.2 Merial Overview 11.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Merial Recent Developments 11.9 Merck Animal Health 11.9.1 Merck Animal Health Corporation Information 11.9.2 Merck Animal Health Overview 11.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Merck Animal Health Recent Developments12 Industry Chain and Sales Channels Analysis 12.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Chain Analysis 12.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Mode & Process 12.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Marketing 12.4.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Channels 12.4.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors 12.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Trends 13.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers 13.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges 13.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints14 Key Findings in The Global Non-steroidal Anti-inflammatory Drugs (NSAID) Study15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer